• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

选择性雌激素受体调节剂 BC-1 通过形成反应性代谢物在体外激活抗氧化信号通路。

Selective estrogen receptor modulator BC-1 activates antioxidant signaling pathway in vitro via formation of reactive metabolites.

机构信息

Key Laboratory of Reproduction and Genetics of Guangdong Higher Education Institute, Third Affiliated Hospital of Guangzhou Medical University, Guangzhou 510150, China.

出版信息

Acta Pharmacol Sin. 2013 Mar;34(3):373-9. doi: 10.1038/aps.2012.168. Epub 2013 Jan 21.

DOI:10.1038/aps.2012.168
PMID:23334240
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4002492/
Abstract

AIM

Benzothiophene compounds are selective estrogen receptor modulators (SERMs), which are recently found to activate antioxidant signaling. In this study the molecular mechanisms of antioxidant signaling activation by benzothiophene compound BC-1 were investigated.

METHODS

HepG2 cells were stably transfected with antioxidant response element (ARE)-luciferase reporter (HepG2-ARE cells). The expression of nuclear factor erythroid 2-related factor 2 (Nrf2) in HepG2-ARE cells was suppressed using siRNA. The metabolites of BC-1 in rat liver microsome incubation were analyzed using LC-UV and LC-MS.

RESULTS

Addition of BC-1 (5 μmol/L) in HepG2-ARE cells resulted in a 17-fold increase of ARE-luciferase activity. Pretreatment with the estrogen receptor agonist E2 (5 μmol/L) or antagonist ICI 182,780 (5 μmol/L) did not affect BC-1-induced ARE-luciferase activity. However, transfection of the cells with anti-Nrf2 siRNA suppressed this effect by 79%. Addition of BC-1 in rat microsome incubation resulted in formation of di-quinone methides and o-quinones, followed by formation of GSH conjugates. BC-1 analogues with hydrogen (BC-2) or fluorine (BC-3) at the 4' position did not form the di-quinone methides. Both BC-2 and BC-3 showed comparable estrogenic activity with BC-1, but did not induce ARE-luciferase activity in HepG2-ARE cells.

CONCLUSION

Benzothiophene compound BC-1 activates ARE signaling via reactive metabolite formation that is independent of estrogen receptors.

摘要

目的

苯并噻吩类化合物是选择性雌激素受体调节剂(SERMs),最近发现它们能激活抗氧化信号。本研究旨在探讨苯并噻吩化合物 BC-1 激活抗氧化信号的分子机制。

方法

用抗氧化反应元件(ARE)-荧光素酶报告基因(HepG2-ARE 细胞)稳定转染 HepG2 细胞。用 siRNA 抑制 HepG2-ARE 细胞中核因子红细胞 2 相关因子 2(Nrf2)的表达。用 LC-UV 和 LC-MS 分析大鼠肝微粒体孵育物中 BC-1 的代谢物。

结果

BC-1(5μmol/L)加入 HepG2-ARE 细胞后,ARE 荧光素酶活性增加 17 倍。用雌激素受体激动剂 E2(5μmol/L)或拮抗剂 ICI 182,780(5μmol/L)预处理并不影响 BC-1 诱导的 ARE 荧光素酶活性。然而,用抗 Nrf2 siRNA 转染细胞可使该作用抑制 79%。BC-1 加入大鼠微粒体孵育物中可形成二醌甲醚和邻醌,随后形成 GSH 结合物。在 4'位带有氢(BC-2)或氟(BC-3)的 BC-1 类似物不能形成二醌甲醚。BC-2 和 BC-3 与 BC-1 具有相似的雌激素活性,但不能诱导 HepG2-ARE 细胞中 ARE 荧光素酶活性。

结论

苯并噻吩化合物 BC-1 通过形成与雌激素受体无关的反应性代谢物激活 ARE 信号。

相似文献

1
Selective estrogen receptor modulator BC-1 activates antioxidant signaling pathway in vitro via formation of reactive metabolites.选择性雌激素受体调节剂 BC-1 通过形成反应性代谢物在体外激活抗氧化信号通路。
Acta Pharmacol Sin. 2013 Mar;34(3):373-9. doi: 10.1038/aps.2012.168. Epub 2013 Jan 21.
2
Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms.改进型苯并噻吩选择性雌激素受体调节剂设计中反应性/活性的结构调控:化学预防机制的诱导
Mol Cancer Ther. 2007 Sep;6(9):2418-28. doi: 10.1158/1535-7163.MCT-07-0268.
3
Schisandrol B protects against acetaminophen-induced acute hepatotoxicity in mice via activation of the NRF2/ARE signaling pathway.五味子醇乙通过激活NRF2/ARE信号通路对乙酰氨基酚诱导的小鼠急性肝毒性具有保护作用。
Acta Pharmacol Sin. 2016 Mar;37(3):382-9. doi: 10.1038/aps.2015.120. Epub 2016 Jan 25.
4
Isoflavone biochanin A, a novel nuclear factor erythroid 2-related factor 2 (Nrf2)-antioxidant response element activator, protects against oxidative damage in HepG2 cells.染料木黄酮生物胆素 A,一种新型核因子红细胞 2 相关因子 2(Nrf2)-抗氧化反应元件激活剂,可防止 HepG2 细胞的氧化损伤。
Biofactors. 2019 Jul;45(4):563-574. doi: 10.1002/biof.1514. Epub 2019 May 27.
5
Chemical modification modulates estrogenic activity, oxidative reactivity, and metabolic stability in 4'F-DMA, a new benzothiophene selective estrogen receptor modulator.化学修饰可调节4'F-DMA(一种新型苯并噻吩选择性雌激素受体调节剂)的雌激素活性、氧化反应性和代谢稳定性。
Chem Res Toxicol. 2006 Jun;19(6):779-87. doi: 10.1021/tx050326r.
6
Corilagin alleviates acetaminophen-induced hepatotoxicity via enhancing the AMPK/GSK3β-Nrf2 signaling pathway.鞣花酸通过增强 AMPK/GSK3β-Nrf2 信号通路缓解对乙酰氨基酚诱导的肝毒性。
Cell Commun Signal. 2019 Jan 10;17(1):2. doi: 10.1186/s12964-018-0314-2.
7
The naphthol selective estrogen receptor modulator (SERM), LY2066948, is oxidized to an o-quinone analogous to the naphthol equine estrogen, equilenin.萘酚选择性雌激素受体调节剂(SERM)LY2066948 被氧化为一种与萘酚马雌激素雌马酚类似的邻醌。
Chem Biol Interact. 2012 Mar 5;196(1-2):1-10. doi: 10.1016/j.cbi.2012.01.004. Epub 2012 Jan 28.
8
Uterine peroxidase-catalyzed formation of diquinone methides from the selective estrogen receptor modulators raloxifene and desmethylated arzoxifene.子宫过氧化物酶催化选择性雌激素受体调节剂雷洛昔芬和去甲基阿佐昔芬形成二醌甲基化物。
Chem Res Toxicol. 2007 Nov;20(11):1676-84. doi: 10.1021/tx7001367. Epub 2007 Jul 13.
9
Deferoxamine promotes osteoblastic differentiation in human periodontal ligament cells via the nuclear factor erythroid 2-related factor-mediated antioxidant signaling pathway.去铁胺通过核因子红细胞2相关因子介导的抗氧化信号通路促进人牙周膜细胞的成骨分化。
J Periodontal Res. 2014 Oct;49(5):563-73. doi: 10.1111/jre.12136. Epub 2013 Oct 1.
10
Ursolic acid sensitizes cisplatin-resistant HepG2/DDP cells to cisplatin via inhibiting Nrf2/ARE pathway.熊果酸通过抑制Nrf2/ARE通路使顺铂耐药的HepG2/DDP细胞对顺铂敏感。
Drug Des Devel Ther. 2016 Oct 25;10:3471-3481. doi: 10.2147/DDDT.S110505. eCollection 2016.

本文引用的文献

1
Chemistry of the cysteine sensors in Kelch-like ECH-associated protein 1.Kelch-like ECH-associated protein 1 中半胱氨酸感受器的化学性质
Antioxid Redox Signal. 2010 Dec 1;13(11):1749-61. doi: 10.1089/ars.2010.3273. Epub 2010 Aug 17.
2
When NRF2 talks, who's listening?当 NRF2 发言时,谁在倾听?
Antioxid Redox Signal. 2010 Dec 1;13(11):1649-63. doi: 10.1089/ars.2010.3216. Epub 2010 Jul 9.
3
Effects of arzoxifene on bone mineral density and endometrium in postmenopausal women with normal or low bone mass.阿佐昔芬对骨量正常或偏低的绝经后女性骨密度及子宫内膜的影响。
J Clin Endocrinol Metab. 2009 Jul;94(7):2284-9. doi: 10.1210/jc.2008-2143. Epub 2009 Apr 7.
4
Selective estrogen receptor modulators: an update on recent clinical findings.选择性雌激素受体调节剂:近期临床研究结果的最新进展
Obstet Gynecol Surv. 2008 Mar;63(3):163-81. doi: 10.1097/OGX.0b013e31816400d7.
5
Differential time-dependent inactivation of P450 3A4 and P450 3A5 by raloxifene: a key role for C239 in quenching reactive intermediates.雷洛昔芬对细胞色素P450 3A4和细胞色素P450 3A5的时间依赖性差异失活作用:C239在淬灭反应性中间体中的关键作用
Chem Res Toxicol. 2007 Dec;20(12):1778-86. doi: 10.1021/tx700207u. Epub 2007 Nov 15.
6
Structural modulation of reactivity/activity in design of improved benzothiophene selective estrogen receptor modulators: induction of chemopreventive mechanisms.改进型苯并噻吩选择性雌激素受体调节剂设计中反应性/活性的结构调控:化学预防机制的诱导
Mol Cancer Ther. 2007 Sep;6(9):2418-28. doi: 10.1158/1535-7163.MCT-07-0268.
7
Identification of cytochrome P450 3A4 modification site with reactive metabolite using linear ion trap-Fourier transform mass spectrometry.利用线性离子阱-傅里叶变换质谱法鉴定细胞色素P450 3A4与反应性代谢物的修饰位点
Chem Res Toxicol. 2007 Oct;20(10):1373-8. doi: 10.1021/tx700165q. Epub 2007 Sep 15.
8
Time-dependent inactivation of P450 3A4 by raloxifene: identification of Cys239 as the site of apoprotein alkylation.雷洛昔芬对细胞色素P450 3A4的时间依赖性失活:确定半胱氨酸239为载脂蛋白烷基化位点。
Chem Res Toxicol. 2007 Jun;20(6):954-64. doi: 10.1021/tx700037e. Epub 2007 May 12.
9
Protective roles of quinone reductase and tamoxifen against estrogen-induced mammary tumorigenesis.醌还原酶和他莫昔芬对雌激素诱导的乳腺肿瘤发生的保护作用。
Oncogene. 2007 May 24;26(24):3587-90. doi: 10.1038/sj.onc.1210144. Epub 2006 Dec 11.
10
The combination of the rexinoid, LG100268, and a selective estrogen receptor modulator, either arzoxifene or acolbifene, synergizes in the prevention and treatment of mammary tumors in an estrogen receptor-negative model of breast cancer.类视黄醇LG100268与选择性雌激素受体调节剂(阿佐昔芬或阿考比芬)联合使用,在雌激素受体阴性乳腺癌模型中对乳腺肿瘤的预防和治疗具有协同作用。
Clin Cancer Res. 2006 Oct 1;12(19):5902-9. doi: 10.1158/1078-0432.CCR-06-1119.